Head-To-Head Review: Terravia (TVIAQ) versus Its Competitors

Terravia (OTCMKTS: TVIAQ) is one of 47 publicly-traded companies in the “Specialty Chemicals” industry, but how does it compare to its competitors? We will compare Terravia to related companies based on the strength of its risk, dividends, analyst recommendations, earnings, institutional ownership, profitability and valuation.

Volatility & Risk

Terravia has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Terravia’s competitors have a beta of 1.38, meaning that their average stock price is 38% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Terravia and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Terravia 0 1 0 0 2.00
Terravia Competitors 175 1050 1322 25 2.47

Terravia presently has a consensus price target of $1.50, suggesting a potential upside of 68,081.82%. As a group, “Specialty Chemicals” companies have a potential downside of 1.79%. Given Terravia’s higher possible upside, analysts clearly believe Terravia is more favorable than its competitors.

Valuation & Earnings

This table compares Terravia and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Terravia $18.48 million -$101.55 million 0.00
Terravia Competitors $1.91 billion $115.73 million 231.36

Terravia’s competitors have higher revenue and earnings than Terravia. Terravia is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

0.2% of Terravia shares are held by institutional investors. Comparatively, 65.1% of shares of all “Specialty Chemicals” companies are held by institutional investors. 10.1% of Terravia shares are held by insiders. Comparatively, 7.4% of shares of all “Specialty Chemicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


This table compares Terravia and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Terravia N/A N/A N/A
Terravia Competitors -657.15% -4.98% -0.18%


Terravia competitors beat Terravia on 8 of the 13 factors compared.

Terravia Company Profile

Solazyme, Inc. creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora S.A. and its affiliates, QVC, Inc., SpaceNK Limited, select Nordstrom stores and ULTA Beauty. It offers intermediates/ingredients, such as Tailored oils, powdered oils, and other closely related products targeted at customers in the industrial products, food products and personal care products markets. The Company’s commercial focus is to sell oils, encapsulated oils and whole algal powdered products to companies that use them as intermediates and ingredients.

Receive News & Ratings for Terravia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terravia and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply